All terms in PATO

Label Id Description
de novo centriole assembly GO_0097742 [Centriole assembly in which a centriole arises de novo, rather than by replication from an existing centriole. This process may occur via different mechanisms. Examples include the deuterosome pathway in multicilated epithelial animal cells and formation of centrioles during parthenogenesis in some insects.]
deuterosome GO_0098536 [A spherical, electron dense, cytoplasmic structure that is involved in de novo assembly of centrioles.]
intracellular membraneless organelle GO_0043232 [Organized structure of distinctive morphology and function, not bounded by a lipid bilayer membrane and occurring within the cell. Includes ribosomes, the cytoskeleton and chromosomes.]
nucleobase-containing molecular entity CHEBI_61120 [Any compound that has a nucleobase as a part.]
nitrogen molecular entity CHEBI_51143
heteroarene CHEBI_33833 [A heterocyclic compound formally derived from an arene by replacement of one or more methine (-C=) and/or vinylene (-CH=CH-) groups by trivalent or divalent heteroatoms, respectively, in such a way as to maintain the continuous pi-electron system characteristic of aromatic systems and a number of out-of-plane pi-electrons corresponding to the Hueckel rule (4n+2).]
norepinephrine secretion GO_0048243 [The regulated release of norepinephrine by a cell. Norepinephrine is a catecholamine and it acts as a hormone and as a neurotransmitter of most of the sympathetic nervous system.]
norepinephrine transport GO_0015874 [The directed movement of norepinephrine into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore. Norepinephrine (3,4-dihydroxyphenyl-2-aminoethanol) is a hormone secreted by the adrenal medulla and a neurotransmitter in the sympathetic peripheral nervous system and in some tracts of the CNS. It is also the biosynthetic precursor of epinephrine.]
catecholamine secretion GO_0050432 [The regulated release of catecholamines by a cell. The catecholamines are a group of physiologically important biogenic amines that possess a catechol (3,4-dihydroxyphenyl) nucleus and are derivatives of 3,4-dihydroxyphenylethylamine.]
secretion GO_0046903 [The controlled release of a substance by a cell or a tissue.]
carbohydrate derivative transport GO_1901264 [The directed movement of a carbohydrate derivative into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.]
cell projection organization GO_0030030 [A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of a prolongation or process extending from a cell, e.g. a flagellum or axon.]
regulation of plasma membrane bounded cell projection organization GO_0120035 [Any process that modulates the frequency, rate or extent of a process involved in the formation, arrangement of constituent parts, or disassembly of plasma membrane bounded cell projections.]
regulation of cell projection organization GO_0031344 [Any process that modulates the frequency, rate or extent of a process involved in the formation, arrangement of constituent parts, or disassembly of cell projections.]
positive regulation of plasma membrane bounded cell projection assembly GO_0120034 [Any process that activates or increases the frequency, rate or extent of plasma membrane bounded cell projection assembly.]
regulation of plasma membrane bounded cell projection assembly GO_0120032 [Any process that modulates the rate, frequency, or extent of plasma membrane bounded cell projection assembly.]
positive regulation of cell projection organization GO_0031346 [Any process that activates or increases the frequency, rate or extent of the process involved in the formation, arrangement of constituent parts, or disassembly of cell projections.]
vesicle fusion with Golgi apparatus GO_0048280 [The joining of the lipid bilayer membrane around a vesicle to the lipid bilayer membrane around the Golgi.]
vesicle fusion GO_0006906 [Fusion of the membrane of a transport vesicle with its target membrane.]
negative regulation of plasma membrane bounded cell projection assembly GO_0120033 [Any process that stops, prevents or reduces the frequency, rate or extent of plasma membrane bounded cell projection assembly.]